-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IHLFzN6zX56rdbVSmt/wAyVmXOYyz18Gf+TTcRpn8eQzDdYsS7ZuQVKeR6Wwnkj7 +IkLCivvEpnBAhM1BHZpyA== 0001140361-10-026843.txt : 20100624 0001140361-10-026843.hdr.sgml : 20100624 20100624163049 ACCESSION NUMBER: 0001140361-10-026843 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100621 FILED AS OF DATE: 20100624 DATE AS OF CHANGE: 20100624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 10915281 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 3 1 doc1.xml FORM 3 X0203 3 2010-06-21 0 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 0 1 0 0 VP, Clinical R&D, CMO Common Stock 14931 D Employee Stock Option (Right to Buy) 4.34 2017-12-12 Common Stock 40000 D Employee Stock Option (Right to Buy) 2.39 2018-06-12 Common Stock 30000 D Restricted Stock Units 0 2019-03-19 Common Stock 30000 D Restricted Stock Units 0 2020-03-22 Common Stock 40000 D Options vest 25% per year on each December 12, of 2008, 2009, 2010 and 2011. Options vest 25% per year on each June 12, 2009, 2010, 2011 and 2012. The restricted stock units will vest 100% on March 10, 2012. 30,000 shares will be delivered to the reporting person on or about that date. The restricted stock units will vest 33.33% on March 22, 2011, 2012, and 2013. 13,334 shares will be delivered to the reporting person on or about March 22, 2011 and 13,333 shares will be delivered to the reporting person on or about each of March 22, 2012 and 2013. /s/ Edward M. Fitzgerald, Attorney-in-fact 2010-06-24 EX-24 2 poa1.htm POWER OF ATTORNEY Unassociated Document
POWER OF ATTORNEY
 


Know all by these presents, that the undersigned hereby constitutes and appoints Harvey J. Berger, M.D., Edward M. Fitzgerald and Raymond T. Keane, Esq. of ARIAD Pharmaceuticals, Inc. (the “Company”), and Jonathan Kravetz, Esq., Scott Samuels, Esq. and Brian Keane, Esq. of Mintz, Levin, Ferris, Glovsky, and Popeo, P.C., signing singly, with full power of substitution, the undersigned’s true and lawful attorney-in-fact to:

(1)           execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director  and/or 10% shareholder of the Company, forms and authentication documents for EDGAR Filing Access;

(2)           do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such forms and authentication documents;

(3)           execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director, and/or 10% shareholder of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder;

(4)           do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(5)           take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interests of, or legally required by the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned 217;s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS THEREOF, the undersigned has caused this Power of Attorney to be executed this 21st day of June 2010.
 
 
  /s/Frank Haluska  
  Signature  
     
     
  Frank Haluska  
  Name  
 
 -----END PRIVACY-ENHANCED MESSAGE-----